Daniel Stauder
Stock Analyst at Citizens JMP
(4.06)
# 1,614
Out of 4,423 analysts
53
Total ratings
48.7%
Success rate
19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintained: Buy | $53 → $48 | $21.19 | +126.52% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $118 → $127 | $93.95 | +35.18% | 11 | May 6, 2026 | |
| ATRC AtriCure | Maintained: Buy | $60 → $52 | $28.80 | +80.56% | 15 | Feb 18, 2026 | |
| STXS Stereotaxis | Initiated Coverage: Buy | $4 | $1.88 | +112.77% | 1 | Dec 16, 2025 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $1.23 | n/a | 6 | Mar 5, 2025 | |
| AVNS Avanos Medical | Reiterated: Hold | n/a | $24.94 | n/a | 10 | Feb 28, 2025 |
Artivion
May 8, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $21.19
Upside: +126.52%
LeMaitre Vascular
May 6, 2026
Maintained: Buy
Price Target: $118 → $127
Current: $93.95
Upside: +35.18%
AtriCure
Feb 18, 2026
Maintained: Buy
Price Target: $60 → $52
Current: $28.80
Upside: +80.56%
Stereotaxis
Dec 16, 2025
Initiated Coverage: Buy
Price Target: $4
Current: $1.88
Upside: +112.77%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $1.23
Upside: n/a
Avanos Medical
Feb 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.94
Upside: n/a